All those trading stock - lesson to be learned is that this stock is a buy and hold. Go back and look each pullback has been met with strong buying and more conviction we are making new highs and higher lows. The fundamentals and catalysts are in place for this to become a solid large biopharma play. My friends in the business are holding onto this for much larger returns from these levels....:)
Agree. Part of it is that the near term drivers are about realized and some retail holders are taking profits. I think mabthera is priced in and some of the other items in flight will drive price to new highs. Until then, volatility.